what's the best glp 1 GLP-1 Drug on the Market Is Even Better Than We Knew management goals. GLP-1 medications are now available

We earn a commission when you purchase products or services through some of the links provided

OvchinnikovAPotekhinaAFilatovaASviridaOZherebchikovaKAgeevFet al

The FDA has specifically identified compounding safety risks

Side Effects Comparison# Retatrutide Side Effects# Phase 2 data (n=338 obesity trial): Nausea : ~25% at higher doses (8-12 mg) Diarrhea : ~20% Vomiting : ~15% Constipation : Common Decreased appetite : Common (pharmacological effect) Heart rate : Small increase (2-4 bpm), potentially related to glucagon component Injection site reactions : Mild, transient Discontinuation rate : 6-10% due to adverse events The glucagon receptor component introduces theoretical concerns for hyperglycemia (counterbalanced by GLP-1/GIP in practice), cardiovascular effects (chronotropic glucagon action), and hepatic effects, none of which produced safety signals in Phase 2 but require larger-scale monitoring